Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Changqing Su
An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Fiber Mediated Receptor Masking in Non-Infected Bystander Cells Restricts Adenovirus Cell Killing Effect but Promotes Adenovirus Host Co-Existence
PLoS ONE
Multidisciplinary
Related publications
Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA
Cancer Research
Cancer Research
Oncology
An Oncolytic Adenovirus That Expresses the HAb18 and Interleukin 24 Genes Exhibits Enhanced Antitumor Activity in Hepatocellular Carcinoma Cells
Oncotarget
Oncology
61PArming Oncolytic Adenovirus With FAP-targeting Bispecific T-Cell Engager to Improve Antitumor Efficacy
Annals of Oncology
Medicine
Oncology
Hematology
Therapeutic Efficacy of an hTERT Promoter-Driven Oncolytic Adenovirus That Expresses Apoptin in Gastric Carcinoma
International Journal of Molecular Medicine
Medicine
Genetics
The Oncolytic Adenovirus Targeting to TERT and RB Pathway Induced Specific and Potent Anti-Tumor Efficacy in Vitro and in Vivo for Hepatocellular Carcinoma
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Dual Promoter-Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
Clinical Cancer Research
Cancer Research
Oncology
Efficacy of a New Oncolytic Adenovirus Armed With IL-13 Against Oral Carcinoma Models
OncoTargets and Therapy
Oncology
Pharmacology
Antitumor Effects of Oncolytic Adenovirus-Carrying siRNA Targeting Potential Oncogene EphA3
PLoS ONE
Multidisciplinary
Oncolytic Adenovirus Loaded With L-Carnosine as Novel Strategy to Enhance the Antitumor Activity
Molecular Cancer Therapeutics
Cancer Research
Oncology
